These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 30089583)

  • 1. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
    Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
    J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
    Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
    Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial interaction and functional status of CD68
    Liu X; Zhang Z; Yuan J; Yu J; Chen D
    Front Immunol; 2024; 15():1396719. PubMed ID: 38799432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung Cancer.
    Schmid S; Csanadi A; Kozhuharov N; Tchudjin M; Kayser C; Rawluk J; Passlick B; Werner M; Prasse A; Kayser G
    Anticancer Res; 2018 Jul; 38(7):3913-3918. PubMed ID: 29970512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma.
    Sun Y; Xu S
    Biomed Res Int; 2018; 2018():8459193. PubMed ID: 29850577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer.
    Jackute J; Zemaitis M; Pranys D; Sitkauskiene B; Miliauskas S; Vaitkiene S; Sakalauskas R
    BMC Immunol; 2018 Jan; 19(1):3. PubMed ID: 29361917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer.
    Dai F; Liu L; Che G; Yu N; Pu Q; Zhang S; Ma J; Ma L; You Z
    BMC Cancer; 2010 May; 10():220. PubMed ID: 20487543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody combinations for optimized staining of macrophages in human lung tumours.
    Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD163
    Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
    Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer.
    Chung FT; Lee KY; Wang CW; Heh CC; Chan YF; Chen HW; Kuo CH; Feng PH; Lin TY; Wang CH; Chou CL; Chen HC; Lin SM; Kuo HP
    Int J Cancer; 2012 Aug; 131(3):E227-35. PubMed ID: 22174092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
    Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
    Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.
    Ohtaki Y; Ishii G; Nagai K; Ashimine S; Kuwata T; Hishida T; Nishimura M; Yoshida J; Takeyoshi I; Ochiai A
    J Thorac Oncol; 2010 Oct; 5(10):1507-15. PubMed ID: 20802348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis.
    Ichimura T; Abe H; Morikawa T; Yamashita H; Ishikawa S; Ushiku T; Seto Y; Fukayama M
    Hum Pathol; 2016 Oct; 56():74-80. PubMed ID: 27342912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer.
    Pei BX; Sun BS; Zhang ZF; Wang AL; Ren P
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1208-1216.e2. PubMed ID: 24907005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.
    Ito M; Ishii G; Nagai K; Maeda R; Nakano Y; Ochiai A
    Chest; 2012 Jul; 142(1):151-158. PubMed ID: 22302300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time.
    Ma J; Liu L; Che G; Yu N; Dai F; You Z
    BMC Cancer; 2010 Mar; 10():112. PubMed ID: 20338029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.